Neodiagnostix
NeoDiagnostix, a Maryland-based medical organization, pioneers personalized cancer care through advanced genomics and diagnostics.
Founded
2005NeoDiagnostix, a Maryland-based medical organization, pioneers personalized cancer care through advanced genomics and diagnostics.
NeoDiagnostix, founded in Rockville, Maryland, is dedicated to revolutionizing personalized cancer care through advanced genomics and diagnostics. The company’s mission is to elevate the standard of care by offering clinicians detailed genomic insights into critical cellular changes linked to DNA damage and cancer. NeoDiagnostix combines cutting-edge molecular DNA technologies with a robust portfolio of proprietary biomarkers to create patient-specific molecular profiles, enabling tailored treatment plans for optimal patient outcomes.
Notable affiliated individuals and investors include leading experts in oncology and genomics, though specific names are not provided. Key achievements include the successful integration of advanced diagnostics with therapeutics, significantly impacting personalized medicine. NeoDiagnostix has made substantial strides in improving clinical decision-making, ultimately enhancing patient care and outcomes in the oncology field.
Companies similar to Neodiagnostix include CancerGuide Diagnostics, NeoGenomics Laboratories, Complete Omics and Personal Genome Diagnostics.
Neodiagnostix was founded in 2005.
Neodiagnostix's headquarters is located in Rockville, MD, US.
Neodiagnostix's most recent funding round was for $1.5M (USD) in October 2009.
As of Oct 24, 2009, Neodiagnostix has disclosed funding of $1.5M (USD). Undisclosed round amounts are excluded.
Neodiagnostix has 9 employees as of Feb 5, 2024.
Personal Genome Diagnostics
personalgenome.com
